FDA Inspection 1210051 — Biofilm, Inc.

Biofilm, Inc. — FEI 2025771

The FDA completed an inspection of Biofilm, Inc. on June 15, 2023 in Vista, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Vista, CA (United States)